Corient Private Wealth
EOLS icon

Corient Private Wealth’s Evolus EOLS Stock Holding History

Corient Private Wealth’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$329K Buy
+79,939
New +$387K ﹤0.01% 2271

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's EOLS Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Evolus (EOLS) in Q1 2026: 79,939 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #2271 among its holdings.

147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Corient Private Wealth held 79,939 shares of Evolus worth $329K as of Q1 2026.
  • Evolus was a new Corient Private Wealth position in Q1 2026.
  • Evolus made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2271 holding.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.